SPARTA, NCT01983241 / 2013-001870-38: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) |
|
|
| Active, not recruiting | 3 | 345 | Europe, Canada, US, RoW | Alpha-1 MP, Prolastin-C, 0.9% Sodium Chloride for Injection, USP, Saline | Grifols Therapeutics LLC | Pulmonary Emphysema in Alpha-1 PI Deficiency | 08/26 | 01/27 | | |
